LuSys Laboratories Covid-19 Antigen Test Recall – Class Action Investigation

Chimicles Schwartz Kriner & Donaldson-Smith (CSK&D) is investigating a potential class action lawsuit related to a recall of at-home coronavirus (COVID-19) tests manufactured by LuSys Laboratories because they do not have Emergency Use Authorization or 510(k)/ PMA clearance and therefore cannot be legally distributed in the United States. Moreover, LuSys Laboratories never provided the required documentation to verify if the tests can perform accurately, posing a risk of offering false negative or positive Covid-19 test results.

These antigen Covid-19 tests are often sold under the company names Luscient Diagnostics, Vivera Pharmaceuticals, and the trade name EagleDX.

If you bought one of these tests, whether or not you have taken the test, we would like to hear from you.

(*) Indicates required field: When communicating with us through this site or otherwise in connection with a matter for which we do not already represent you, your communication may not be treated as privileged or confidential, and does not create an attorney-client relationship between you and our Firm.

Attorneys for this case:

Benjamin F. Johns